Follow Important Email Alerts on Stocks like CYDY from SpeculatingStocks.com.
CYDY 'Buy' / 'Sell' Stats
Sentiment Over the Last:
10-Mins: B:0 S:0
1-Hour: B:0 S:0
6-Hours: B:0 S:0
1-Day: B:0 S:0
3-Days: B:0 S:0
1-Week: B:0 S:0
and more... sign up .
More CYDY Social Data
Top Stories Today 2m
Followers: 1
'Buys' : 0
'Sells' : 14
'Buys' 7 AM :
0
'Sells' 7 AM :
0
CytoDyn Inc. ($CYDY)
Duh Bag sHorT by fIVe uv Uz
$CYDY saNta raiNdEar tO shoRtie iTie to dEaThie mAtt gEtZ oUt
$CYDY CytoDyn partner Biomm S.A. plans to submit authorization to conduct Phase 3 clinical studies of leronlimab with ANVISA in Brazil in the next few days.
$CYDY CytoDyn to submit newly completed topline report of CD12 trial results to regulatory agencies in multiple countries including India and Philippines.
$CYDY CytoDyn announced its drug candidate, leronlimab, will be featured in a one-hour news segment May 9 on OneNews in the Philippines.
$CYDY CytoDyn submitted first and most crucial section of interim order application to Health Canada for COVID-19 under rolling review.
$CYDY CytoDyn COVID-19 long-hauler's trial closed as enrollment exceeds goals.
$CYDY CytoDyn delivered leronlimab to COVID-19 patients in Philippines hospital under Compassionate Special Permit.
$CYDY CytoDyn delivered leronlimab to COVID-19 patients in Philippines hospital under Compassionate Special Permit.
$CYDY CytoDyn signed exclusive supply and distribution agreement with Biomm S.A. in Brazil for COVID-19 and all other leronlimab indications.
$CYDY CytoDyn's leronlimab decreased mortality at 14 days by 82% with statistically significant p-value of 0.0233 amongst critically ill COVID-19 patients.
$CYDY CytoDyn: The Philippines FDA approved the use of leronlimab to treat a COVID-19 patient.
$CYDY CytoDyn appointed Christopher Recknor, as COO.
$CYDY CytoDyn to file accelerated rolling review with MHRA and Interim Order (IO) with Health Canada for COVID-19.
$CYDY CytoDyn to release CD12 trial detailed results via form 8-K after investment community webcast, Monday, March 8.
$CYDY CytoDyn phase 3 trial demonstrated safety, a 24% reduction in mortality and faster hospital discharge for mechanically ventilated critically ill COVID-19 patients treated with leronlimab.
Go to Reactions Related to CYDY!
What stock do you like next?
$CYDY looked like a nice double for you.
More than 6 mos ago |
0 buys,
0 sells
Moments ago |
0 buys,
0 sells
CYDY Sentiment Today (Since 7 AM ET)
Copy the Widget Code for CYDY
The Revolution in Speculation Continues...
24,465 symbol pages... 1224
users... 2,971,357 pulses... not one
unhappy user. Sign up now, free! Newest SpeculatingStocks Pulse User AlVitali
Headlines for CytoDyn Inc. (CYDY)
